Aranotin

This classification denotes an antiviral agent with the molecular formula C20H18N2O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H56CKB2FFV, chemically known as 5,5a,13,13a-tetrahydro-5,13-dihydroxy-8h,16h-7a,15a-epidithio-7h,15h-bisoxepino(3,4:4,5)pyrrolo(1,2-a:1,2-d)pyrazine-7,15-dione 5-acetate but generally known as aranotin, which bears US NIH Compound Identifier 29844. European Medicines Agency schedules Aranotin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05551MIG. The term ARANOTIN is an International Non-Proprietary Name. ARANOTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aranotin under HS 29349990 and SITC 51579. As of Q4 2014, ARANOTIN remains the US FDA Preferred Term for this commodity. Aranotin bears US NLM identifiers UMLS ID C0052306 and NCI Concept Code C81609. SMILES: S1SC23N(C4C(=COC=CC4O)C2)C(=O)C21N(C1C(=COC=CC1OC(=O)C)C2)C3=O.